Post-Chemoradiation Metastatic, Persistent and Resistant Nodes in Locally Advanced Rectal Cancer: Metrics and Their Impact on Long-Term Outcome

被引:1
作者
Calvo, Felipe A. [1 ,2 ]
Tudela, Maria [1 ]
Serrano, Javier [2 ]
Munoz-Fernandez, Mercedes [1 ]
Peligros, Maria Isabel [1 ]
Garcia-Alfonso, Pilar [1 ]
del Valle, Emilio [1 ]
机构
[1] Hosp Gen Univ Gregorio Maranon, Madrid 28007, Spain
[2] Clin Univ Navarra, Dept Oncol, Madrid 28027, Spain
关键词
post-chemoradiation metastatic; locally advanced rectal cancer; neoadjuvant therapy; intraoperative electrons; nodal metastases; chemotherapy; SURGICAL ORGAN DISPLACEMENT; DISEASE-FREE SURVIVAL; PREOPERATIVE CHEMORADIOTHERAPY; NEOADJUVANT CHEMORADIATION; ADJUVANT CHEMOTHERAPY; LYMPH-NODE; PROGNOSTIC-SIGNIFICANCE; RADIATION-THERAPY; RADICAL SURGERY; RECURRENCE;
D O I
10.3390/cancers15184591
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The purpose of this study was to evaluate the long-term oncological progression pattern of locally advanced rectal cancer patients with post-neoadjuvant nodal metastatic disease (ypN+) and correlate potential prognostic features associated with proven radiochemoresistant nodal biology. Methods: Individual patient data (100 variables) from a 20-year consecutive single-institution multidisciplinary experience (1995-2015), delivering multimodal therapy to rectal cancer patient candidates for radical treatment, including a neoadjuvant component and surgical resection with or without intraoperative radiotherapy followed by optional adjuvant chemotherapy. The ypN+ disease data was registered in the context of initial staging categories post-neoadjuvant T status (ypT). Results: Data on 487 patients showed histologically confirmed diagnoses of metastatic nodal disease in 108 specimens (ypN+, 22.1). There was a significant age difference (p = 0.009) between the ypN groups: age >= 65 was 57.6% in pN0 and 43.5% in ypN+ and patients aged < 65 constituted 42.4% of pN0 and 56.5% of ypN+. According to the clinical stage there were statistically significant differences (p = 0.001) in the categories' distribution: ypN+ patients 10.8% were stage II and 89.2% were stage III. Univariant analysis on outcome variables showed statistically significant differences in overall survival at 7 years (63.8% vs. 55.7%, p = 0.016) disease-free survival (DFS) (78% vs. 53.8%, p = 0.000) and local recurrence-free survival (LRFS) (93.6% vs. 84%, p = 0.002). Conclusions: The presence of nodal metastases (ypN+) after neoadjuvant therapy containing long-course pelvic irradiation severely impacts the long-term outcome for patients with locally advanced rectal cancer and correlates with multiple clinical and therapeutic variable metrics. Implementation of local and systemic therapies should be adapted and intensified in relation to the finding of ypN+ category in surgical specimens.
引用
收藏
页数:20
相关论文
共 35 条
  • [1] The effect of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery in patients who are histologically node negative after neoadjuvant chemoradiotherapy
    Baird, D. L. H.
    Denost, Q.
    Simillis, C.
    Pellino, G.
    Rasheed, S.
    Kontovounisios, C.
    Tekkis, P. P.
    Rullier, E.
    [J]. COLORECTAL DISEASE, 2017, 19 (11) : 980 - 986
  • [2] Pathologic evaluation of the response of mesorectal positive nodes to preoperative chemoradiotherapy in patients with rectal cancer
    Beppu, Naohito
    Matsubara, Nagabide
    Noda, Masashi
    Yamano, Tomoki
    Kakuno, Ayako
    Doi, Hiroshi
    Kamikonya, Norihiko
    Yamanaka, Naoki
    Yanagi, Hidenori
    Tomita, Naohiro
    [J]. SURGERY, 2015, 157 (04) : 743 - 751
  • [3] Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation
    Calvo, F. A.
    Serrano, F. J.
    Diaz-Gonzalez, J. A.
    Gomez-Espi, M.
    Lozano, E.
    Garcia, R.
    de la Mata, D.
    Arranz, J. A.
    Garcia-Alfonso, P.
    Perez-Manga, G.
    Alvarez, E.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (07) : 1103 - 1110
  • [4] ESTRO/ACROP IORT recommendations for intraoperative radiation therapy in primary locally advanced rectal cancer
    Calvo, Felipe A.
    Sole, Claudio V.
    Rutten, Harm J.
    Poortmans, Philip
    Asencio, Jose M.
    Serrano, Javier
    Aristu, Javier
    Roeder, Falk
    Dries, Wim J.
    [J]. CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2020, 25 : 29 - 36
  • [5] Practice-oriented solutions integrating intraoperative electron irradiation and personalized proton therapy for recurrent or unresectable cancers: Proof of concept and potential for dual FLASH effect (VOL 12, 1037262, 2022)
    Calvo, Felipe A. A.
    Ayestaran, Adriana
    Serrano, Javier
    Cambeiro, Mauricio
    Palma, Jacobo
    Meirino, Rosa
    Morcillo, Miguel A. A.
    Lapuente, Fernando
    Chiva, Luis
    Aguilar, Borja
    Azcona, Diego
    Pedrero, Diego
    Pascau, Javier
    Delgado, Jose Miguel
    Aristu, Javier
    Alonso, Alberto
    Prezado, Yolanda
    [J]. FRONTIERS IN ONCOLOGY, 2023, 12
  • [6] Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: Long-term analysis of 566 ypcr patients
    Capirci, Carlo
    Valentini, Vincenzo
    Cionini, Luca
    De Paoli, Antonino
    Rodel, Claus
    Glynne-Jones, Robert
    Coco, Claudio
    Romano, Mario
    Mantello, Giovanna
    Palazzi, Silvia
    Mattia, Falchetti Osti
    Friso, Maria Luisa
    Genovesi, Domenico
    Vidali, Cristiana
    Gambacorta, Maria Antonietta
    Buffoli, Alberto
    Lupattelli, Marco
    Favretto, Maria Silvia
    La Torre, Giuseppe
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : 99 - 107
  • [7] Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy
    Chan, AKP
    Wong, A
    Jenken, D
    Heine, J
    Buie, D
    Johnson, D
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (03): : 665 - 677
  • [8] Rectal cancer patients after neoadjuvant radiotherapy (30Gy/10f) with negative lymph node may not benefit from postoperative adjuvant chemotherapy: a retrospective study
    Chen, Pengju
    Yao, Yunfeng
    Gu, Jin
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2015, 30 (12) : 1695 - 1704
  • [9] Adjuvant Treatment for Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy: When, and for Whom?
    De Stefano, Alfonso
    Moretto, Roberto
    Bucci, Luigi
    Pepe, Stefano
    Romano, Francesco Jacopo
    Cella, Alessandra Chiara
    Attademo, Laura
    Rosanova, Mario
    De Falco, Stefano
    Fiore, Giovanni
    Raimondo, Lucia
    De Placido, Sabino
    Carlomagno, Chiara
    [J]. CLINICAL COLORECTAL CANCER, 2014, 13 (03) : 185 - 191
  • [10] Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification
    Dekker, J. W. T.
    Peeters, K. C.
    Putter, H.
    Vahrmeijer, A. L.
    van de Velde, C. J. H.
    [J]. EJSO, 2010, 36 (12): : 1180 - 1186